MAUDE Adverse Event Report: EBI, LLC. BIOMET EBI BONE HEALING SYSTEM; STIMULATOR, BONE GROWTH, NON-INVASIVE

Model Number	1068234
Medical Device Problem Code	Patient-Device Incompatibility (2682)
Health Effect - Clinical Code	Pain (1994)
Type of Reportable Event	Serious Injury
Event or Problem Description
It was reported that the patient experienced excruciating pain after 2 hours of treatment.The patient stated that she is fine all day with no pain but after about 1 hour of treatment the pain starts.The patient stated that last night the pain got so bad she had to take an oxycodone.The patient has not discussed the issue with her doctor.The patient stated she has never spoken with a sales representative.Product surveillance specialist (b)(6) gave the patient the phone number for (b)(6) who is listed as the sales representative in filenet and advised the patient to contact the sales rep with the concern.Note: this information was obtained during second attempt call for (b)(4).Update 8/12: per second attempt call, the patient stated that she had to stop using the unit due to the pain.The patient stated that the pain was excruciating, rated the pain an 8 or 9 out of 10.The patient reached out to her doctor to discuss getting more pain medication but her doctor advised her to stop using the unit instead.The patient was asked if she would like to return the device for evaluation and stated she would have to discuss with her doctor, the patient may want to resume treatment at some point.The patient was transferred to pag to discuss her options.
Additional Manufacturer Narrative
The device was not returned to (b)(6) medical for evaluation, therefore no product evaluation has been conducted.The reported event was unable to be confirmed due to limited information received from the customer.The device history record was reviewed, and no discrepancies related to the reported event were found.Root cause was unable to be determined as the necessary information to adequately investigate the reported event was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.(b)(6) medical will continue to monitor trends.
Event or Problem Description
It was reported that the patient experienced excruciating pain after 2 hours of treatment.The patient stated that she is fine all day with no pain but after about 1 hour of treatment the pain starts.The patient stated that last night the pain got so bad she had to take an oxycodone.The patient has not discussed the issue with her doctor.The patient stated she has never spoken with a sales representative.Product surveillance specialist (b)(4) gave the patient the phone number for susan rendulic who is listed as the sales representative in filenet and advised the patient to contact the sales rep with the concern.Note, this information was obtained during second attempt call for (b)(4); (b)(4).Update (b)(6): per second attempt call, the patient stated that she had to stop using the unit due to the pain.The patient stated that the pain was excruciating, rated the pain an 8 or 9 out of 10.The patient reached out to her doctor to discuss getting more pain medication but her doctor advised her to stop using the unit instead.The patient was asked if she would like to return the device for evaluation and stated she would have to discuss with her doctor, the patient may want to resume treatment at some point.The patient was transferred to (b)(6) to discuss her options.
Additional Manufacturer Narrative
Additional information in the following fields, b4: date of this report, g3: date received by manufacturer.This follow-up report is being submitted to relay additional and corrected information.The device was not returned to ebi for evaluation.The reported event was unable to be confirmed due to limited information received from the customer.The device history record was reviewed, and no discrepancies related to the reported event were found.Root cause was unable to be determined as the necessary information to adequately investigate the reported event was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.

• Brand Name: BIOMET EBI BONE HEALING SYSTEM
• Common Device Name: STIMULATOR, BONE GROWTH, NON-INVASIVE
• Manufacturer (Section D): EBI, LLC.; 1 gatehall dr; suite 303; parsippany NJ 07054
• Manufacturer (Section G): EBI, LLC; 1 gatehall dr; suite 303; parsippany NJ 07054
• Manufacturer Contact: stephanie smith ; 1 gatehall dr; suite 303; parsippany, NJ 07054 ; 9732999300
• MDR Report Key: 22926713
• Report Number: 0002242816-2025-00106
• Device Sequence Number: 15742383
• Product Code: LOF
• UDI-Device Identifier: 00812301020560
• UDI-Public: 00812301020560
• Combination Product (Y/N): N
• Initial Reporter State: WV
• Initial Reporter Country: US
• PMA/510(K) Number: P790002
• Exemption Number: 5645646
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Consumer
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup
• Report Date (Section B): 11/18/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Lay User/Patient
• Device Model Number: 1068234
• Device Catalogue Number: 1068234
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: Not provided
• Supplement Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 08/29/2025
• Supplement Report FDA Received Date: 11/19/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 06/03/2025
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Unknown
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: SEE H10 NARRATIVE.; SEE H10 NARRATIVE.
• Patient Age: 45 YR
• Patient Sex: Female
• Patient Ethnicity: Non Hispanic